Stay updated with breaking news from Global Impression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Positive top-line results from Phase 3 PALISADE-2 trial of rapid-onset fasedienol (PH94B) nasal spray in social anxiety disorder (SAD)Itruvone (PH10) nasal spray now staged for Phase 2B clinical development as a stand-alone, non-systemic treatment for major depressive disorder (MDD)Positive exploratory Phase 2A tria...
Positive top-line results from Phase 3 PALISADE-2 trial of rapid-onset fasedienol nasal spray in social anxiety disorder Itruvone nasal spray now staged for Phase 2B clinical development as a... -Today at 04:23 pm- MarketScreener
Vistagen reported significant improvement of physician- and patient-reported anxiety among trial participants who underwent an anxiety-inducing public speaking exercise.
First positive U.S. Phase 3 study of an investigational therapy for social anxiety disorder in over 15 years Statistically significant rapid-onset reduction in patient-reported Subjective Units of...
Vistagen announced positive top-line results from its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of fasedienol nasal spray in adults diagnosed with social anxiety...